BE
Bonness Enterprises Portfolio holdings
AUM
$305M
This Quarter Return
-2.39%
1 Year Return
+20.16%
3 Year Return
+82.96%
5 Year Return
+156.72%
10 Year Return
+388.32%
AUM
$196M
AUM Growth
+$196M
(-1.2%)
Cap. Flow
-$6.34M
Cap. Flow
% of AUM
-3.23%
Top 10 Holdings %
Top 10 Hldgs %
64.03%
Holding
40
New
–
Increased
1
Reduced
2
Closed
–
Top Buys
| 1 |
Progressive
PGR
|
$3.01M |
Top Sells
| 1 |
GE Aerospace
GE
|
$9.34M |
| 2 |
Organon & Co
OGN
|
$6.55K |
Sector Composition
| 1 | Financials | 31.4% |
| 2 | Healthcare | 29.52% |
| 3 | Technology | 24.48% |
| 4 | Industrials | 4.16% |
| 5 | Consumer Staples | 4.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Progressive
PGR
$145B
| $54.8M | 27.92% |
605,853
+33,245
| +6% | +$3.01M |
|
2
Stryker
SYK
$150B
| $18M | 9.2% |
68,400
| – | – |
|
3
Microsoft
MSFT
$3.77T
| $13.1M | 6.67% |
46,400
| – | – |
|
4
Apple
AAPL
$3.45T
| $7.77M | 3.96% |
54,940
| – | – |
|
5
Thermo Fisher Scientific
TMO
$186B
| $6.51M | 3.32% |
11,400
| – | – |
|
6
Johnson & Johnson
JNJ
$427B
| $6.29M | 3.21% |
38,938
| – | – |
|
7
Merck
MRK
$210B
| $5.22M | 2.66% |
69,500
| – | – |
|
8
Intel
INTC
$107B
| $4.74M | 2.42% |
88,950
| – | – |
|
9
Nucor
NUE
$34.1B
| $4.66M | 2.38% |
47,350
| – | – |
|
10
Cisco
CSCO
$274B
| $4.51M | 2.3% |
82,900
| – | – |
|
11
Unilever
UL
$155B
| $4.12M | 2.1% |
76,040
| – | – |
|
12
Emerson Electric
EMR
$74.3B
| $4.1M | 2.09% |
43,500
| – | – |
|
13
IBM
IBM
$227B
| $4.09M | 2.09% |
29,464
| – | – |
|
14
Applied Materials
AMAT
$128B
| $4.03M | 2.05% |
31,300
| – | – |
|
15
AbbVie
ABBV
$372B
| $3.95M | 2.01% |
36,600
| – | – |
|
16
Marsh & McLennan
MMC
$101B
| $3.91M | 1.99% |
25,800
| – | – |
|
17
Abbott
ABT
$231B
| $3.86M | 1.97% |
32,700
| – | – |
|
18
Pfizer
PFE
$141B
| $3.38M | 1.72% |
78,608
| – | – |
|
19
Bristol-Myers Squibb
BMY
$96B
| $3.14M | 1.6% |
53,100
| – | – |
|
20
Agilent Technologies
A
$35.7B
| $2.82M | 1.44% |
17,900
| – | – |
|
21
United Parcel Service
UPS
$74.1B
| $2.72M | 1.39% |
14,950
| – | – |
|
22
John Wiley & Sons Class A
WLY
$2.16B
| $2.53M | 1.29% |
48,400
| – | – |
|
23
GSK
GSK
$79.9B
| $2.45M | 1.25% |
64,200
| – | – |
|
24
AT&T
T
$209B
| $2.4M | 1.22% |
88,900
| – | – |
|
25
Procter & Gamble
PG
$368B
| $2.29M | 1.17% |
16,400
| – | – |
|